Literature DB >> 25179139

High resolution 3D MRI of mouse mammary glands with intra-ductal injection of contrast media.

Erica Markiewicz1, Xiaobing Fan1, Devkumar Mustafi1, Marta Zamora1, Brian B Roman1, Sanaz A Jansen1, Kay Macleod2, Suzanne D Conzen3, Gregory S Karczmar4.   

Abstract

The purpose of this study was to use high resolution three-dimensional (3D) magnetic resonance imaging (MRI) to study mouse mammary gland ductal architecture based on intra-ductal injection of contrast agents. Female FVB/N mice age 12-20 weeks (n=12), were used in this study. A 34G, 45° tip Hamilton needle with a 25μL Hamilton syringe was inserted into the tip of the nipple. Approximately 20-25μL of a Gadodiamide/Trypan blue/saline solution was injected slowly over one minute into the nipple and duct. To prevent washout of contrast media from ducts due to perfusion, and maximize the conspicuity of ducts on MRI, mice were sacrificed one minute after injection. High resolution 3D T1-weighted images were acquired on a 9.4T Bruker scanner after sacrifice to eliminate motion artifacts and reduce contrast media leakage from ducts. Trypan blue staining was well distributed throughout the ductal tree. MRI showed the mammary gland ductal structure clearly. In spoiled gradient echo T1-weighted images, the signal-to-noise ratio of regions identified as enhancing mammary ducts following contrast injection was significantly higher than that of muscle (p<0.02) and significantly higher than that of contralateral mammary ducts that were not injected with contrast media (p<0.0001). The methods described here could be adapted for injection of specialized contrast agents to measure metabolism or target receptors in normal ducts and ducts with in situ cancers.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D MRI; Contrast agent; Ductal injection; Mouse mammary gland

Mesh:

Substances:

Year:  2014        PMID: 25179139      PMCID: PMC4267960          DOI: 10.1016/j.mri.2014.08.035

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  13 in total

Review 1.  MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge.

Authors:  Masanori Hirose; Hiroshi Nobusawa; Takehiko Gokan
Journal:  Radiographics       Date:  2007-10       Impact factor: 5.333

2.  In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica Markiewicz; Thomas Krausz; Gillian M Newstead; Gregory S Karczmar
Journal:  NMR Biomed       Date:  2011-01-25       Impact factor: 4.044

Review 3.  The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Authors:  J E Green; M A Shibata; K Yoshidome; M L Liu; C Jorcyk; M R Anver; J Wigginton; R Wiltrout; E Shibata; S Kaczmarczyk; W Wang; Z Y Liu; A Calvo; C Couldrey
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

4.  Ductal access for prevention and therapy of mammary tumors.

Authors:  Satoshi Murata; Scott L Kominsky; Mustafa Vali; Zhe Zhang; Elizabeth Garrett-Mayer; Dorian Korz; David Huso; Sharyn D Baker; James Barber; Elizabeth Jaffee; R Todd Reilly; Saraswati Sukumar
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  Multi-volume fusion imaging of MR ductography and MR mammography for patients with nipple discharge.

Authors:  Masanori Hirose; Noriko Otsuki; Daisuke Hayano; Hidenori Shinjo; Takehiko Gokan; Tatsuhisa Kashiwase; Kenya Suzuki; Terumasa Sawada
Journal:  Magn Reson Med Sci       Date:  2006-07       Impact factor: 2.471

6.  Methods for preparing fluorescent and neutral red-stained whole mounts of mouse mammary glands.

Authors:  John D Landua; Adriana P Visbal; Michael T Lewis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-11-24       Impact factor: 2.673

7.  Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.

Authors:  Sanaz A Jansen; Tatjana Paunesku; Xiaobing Fan; Gayle E Woloschak; Stefan Vogt; Suzanne D Conzen; Thomas Krausz; Gillian M Newstead; Gregory S Karczmar
Journal:  Radiology       Date:  2009-11       Impact factor: 11.105

8.  Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.

Authors:  Kazuhiko Tsuji; Meng Yang; Ping Jiang; Anirban Maitra; Sharmeela Kaushal; Kensuke Yamauchi; Matthew H Katz; Abdool R Moossa; Robert M Hoffman; Michael Bouvet
Journal:  JOP       Date:  2006-03-09

9.  Intraductal injection for localized drug delivery to the mouse mammary gland.

Authors:  Silva Krause; Amy Brock; Donald E Ingber
Journal:  J Vis Exp       Date:  2013-10-04       Impact factor: 1.355

10.  An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ.

Authors:  Fariba Behbod; Frances S Kittrell; Heather LaMarca; David Edwards; Sofia Kerbawy; Jessica C Heestand; Evelin Young; Purna Mukhopadhyay; Hung-Wen Yeh; D Craig Allred; Min Hu; Kornelia Polyak; Jeffrey M Rosen; Daniel Medina
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more
  2 in total

1.  Monitoring In-Vivo the Mammary Gland Microstructure during Morphogenesis from Lactation to Post-Weaning Using Diffusion Tensor MRI.

Authors:  Noam Nissan; Edna Furman-Haran; Myra Shapiro-Feinberg; Dov Grobgeld; Hadassa Degani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-07-13       Impact factor: 2.673

2.  MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer.

Authors:  Erica Markiewicz; Xiaobing Fan; Devkumar Mustafi; Marta Zamora; Suzanne D Conzen; Gregory S Karczmar
Journal:  Magn Reson Imaging       Date:  2017-03-30       Impact factor: 2.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.